Longboard Pharmaceuticals, Inc. (LBPH)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Longboard Pharmaceuticals, Inc. (LBPH)
Company Performance

Current Price

as of Oct 16, 2024

$59.40

P/E Ratio

N/A

Market Cap

$2.04B

Description

Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for neurological diseases. The company was founded on January 3, 2020 and is headquartered in San Diego, CA.

Metrics

Overview

  • HQLa Jolla, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerLBPH
  • Price$59.4+0.54%

Trading Information

  • Market Cap$2.04B
  • Float86.35%
  • Average Daily Volume (1m)3,365,489
  • Average Daily Volume (3m)1,482,113
  • EPS-$2.16

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$21.79M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$25.64M
  • EV$749.92M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B7.84